178 related articles for article (PubMed ID: 25581217)
1. Low-Magnitude Mechanical Stimulation to Improve Bone Density in Persons of Advanced Age: A Randomized, Placebo-Controlled Trial.
Kiel DP; Hannan MT; Barton BA; Bouxsein ML; Sisson E; Lang T; Allaire B; Dewkett D; Carroll D; Magaziner J; Shane E; Leary ET; Zimmerman S; Rubin CT
J Bone Miner Res; 2015 Jul; 30(7):1319-28. PubMed ID: 25581217
[TBL] [Abstract][Full Text] [Related]
2. Effect of 12 months of whole-body vibration therapy on bone density and structure in postmenopausal women: a randomized trial.
Slatkovska L; Alibhai SM; Beyene J; Hu H; Demaras A; Cheung AM
Ann Intern Med; 2011 Nov; 155(10):668-79, W205. PubMed ID: 22084333
[TBL] [Abstract][Full Text] [Related]
3. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
4. Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
Khan AA; Bilezikian JP; Kung AW; Ahmed MM; Dubois SJ; Ho AY; Schussheim D; Rubin MR; Shaikh AM; Silverberg SJ; Standish TI; Syed Z; Syed ZA
J Clin Endocrinol Metab; 2004 Jul; 89(7):3319-25. PubMed ID: 15240609
[TBL] [Abstract][Full Text] [Related]
5. The combined effect of Parathyroid hormone (1-34) and whole-body Vibration exercise in the treatment of OSteoporosis (PaVOS)- study protocol for a randomized controlled trial.
Jepsen DB; Ryg J; Jørgensen NR; Hansen S; Masud T
Trials; 2018 Mar; 19(1):186. PubMed ID: 29548300
[TBL] [Abstract][Full Text] [Related]
6. Insights from the conduct of a device trial in older persons: low magnitude mechanical stimulation for musculoskeletal health.
Kiel DP; Hannan MT; Barton BA; Bouxsein ML; Lang TF; Brown KM; Shane E; Magaziner J; Zimmerman S; Rubin CT
Clin Trials; 2010 Aug; 7(4):354-67. PubMed ID: 20571129
[TBL] [Abstract][Full Text] [Related]
7. Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trial.
Grey A; Bolland M; Mihov B; Wong S; Horne A; Gamble G; Reid IR
J Bone Miner Res; 2014 Jan; 29(1):166-72. PubMed ID: 23761303
[TBL] [Abstract][Full Text] [Related]
8. Effect of whole body vibration training on bone mineral density and bone quality in adolescents with Down syndrome: a randomized controlled trial.
Matute-Llorente A; González-Agüero A; Gómez-Cabello A; Olmedillas H; Vicente-Rodríguez G; Casajús JA
Osteoporos Int; 2015 Oct; 26(10):2449-59. PubMed ID: 25994905
[TBL] [Abstract][Full Text] [Related]
9. Effects of whole body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
Oliveira LC; Oliveira RG; Pires-Oliveira DA
Osteoporos Int; 2016 Oct; 27(10):2913-33. PubMed ID: 27145947
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.
Ensrud KE; Barrett-Connor EL; Schwartz A; Santora AC; Bauer DC; Suryawanshi S; Feldstein A; Haskell WL; Hochberg MC; Torner JC; Lombardi A; Black DM;
J Bone Miner Res; 2004 Aug; 19(8):1259-69. PubMed ID: 15231012
[TBL] [Abstract][Full Text] [Related]
11. Effect of Low-Magnitude, High-Frequency Mechanical Stimulation on BMD Among Young Childhood Cancer Survivors: A Randomized Clinical Trial.
Mogil RJ; Kaste SC; Ferry RJ; Hudson MM; Mulrooney DA; Howell CR; Partin RE; Srivastava DK; Robison LL; Ness KK
JAMA Oncol; 2016 Jul; 2(7):908-14. PubMed ID: 26967465
[TBL] [Abstract][Full Text] [Related]
12. Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety.
Rubin C; Recker R; Cullen D; Ryaby J; McCabe J; McLeod K
J Bone Miner Res; 2004 Mar; 19(3):343-51. PubMed ID: 15040821
[TBL] [Abstract][Full Text] [Related]
13. Effect of Low-Magnitude Mechanical Stimuli on Bone Density and Structure in Pediatric Crohn's Disease: A Randomized Placebo-Controlled Trial.
Leonard MB; Shults J; Long J; Baldassano RN; Brown JK; Hommel K; Zemel BS; Mahboubi S; Howard Whitehead K; Herskovitz R; Lee D; Rausch J; Rubin CT
J Bone Miner Res; 2016 Jun; 31(6):1177-88. PubMed ID: 26821779
[TBL] [Abstract][Full Text] [Related]
14. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
Deal C; Omizo M; Schwartz EN; Eriksen EF; Cantor P; Wang J; Glass EV; Myers SL; Krege JH
J Bone Miner Res; 2005 Nov; 20(11):1905-11. PubMed ID: 16234962
[TBL] [Abstract][Full Text] [Related]
15. Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.
Grey A; Bolland MJ; Horne A; Wattie D; House M; Gamble G; Reid IR
Bone; 2012 Jun; 50(6):1389-93. PubMed ID: 22465268
[TBL] [Abstract][Full Text] [Related]
16. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
[TBL] [Abstract][Full Text] [Related]
17. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.
Adachi JD; Saag KG; Delmas PD; Liberman UA; Emkey RD; Seeman E; Lane NE; Kaufman JM; Poubelle PE; Hawkins F; Correa-Rotter R; Menkes CJ; Rodriguez-Portales JA; Schnitzer TJ; Block JA; Wing J; McIlwain HH; Westhovens R; Brown J; Melo-Gomes JA; Gruber BL; Yanover MJ; Leite MO; Siminoski KG; Nevitt MC; Sharp JT; Malice MP; Dumortier T; Czachur M; Carofano W; Daifotis A
Arthritis Rheum; 2001 Jan; 44(1):202-11. PubMed ID: 11212161
[TBL] [Abstract][Full Text] [Related]
18. Effect of whole-body vibration on BMD: a systematic review and meta-analysis.
Slatkovska L; Alibhai SM; Beyene J; Cheung AM
Osteoporos Int; 2010 Dec; 21(12):1969-80. PubMed ID: 20407890
[TBL] [Abstract][Full Text] [Related]
19. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density, microarchitectural and mechanical alterations of osteoporotic rat bone under long-term whole-body vibration therapy.
Xie P; Tang Z; Qing F; Chen X; Zhu X; Fan Y; Yang X; Zhang X
J Mech Behav Biomed Mater; 2016 Jan; 53():341-349. PubMed ID: 26398779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
